Cargando…
PTH 1-34 promoted bone formation by regulating iron metabolism in unloading-induced bone loss
PTH 1-34 (teriparatide) is approved by FDA for the treatment of postmenopausal osteoporosis. Iron overload is a major contributing factor for bone loss induced by unloading. Whether iron metabolism is involved in the regulation of PTH 1-34 on unloading-induced osteoporosis has not yet been reported....
Autores principales: | Che, Jingmin, Ren, Weihao, Chen, Xin, Wang, Fang, Zhang, Gejing, Shang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933505/ https://www.ncbi.nlm.nih.gov/pubmed/36818465 http://dx.doi.org/10.3389/fendo.2022.1048818 |
Ejemplares similares
-
1–2 T static magnetic field combined with Ferumoxytol prevent unloading-induced bone loss by regulating iron metabolism in osteoclastogenesis
por: Zhang, Gejing, et al.
Publicado: (2022) -
Interactome of PTH-Regulated miRNAs and Their Predicted Target Genes for Investigating the Epigenetic Effects of PTH (1–34) in Bone Metabolism
por: Vrščaj, Lucija Ana, et al.
Publicado: (2022) -
PTH1R Actions on Bone Using the cAMP/Protein Kinase A Pathway
por: Martin, T. John
Publicado: (2022) -
Pre-flight exercise and bone metabolism predict unloading-induced bone loss due to spaceflight
por: Gabel, Leigh, et al.
Publicado: (2022) -
Disruption of PTH Receptor 1 in T Cells Protects against PTH-Induced Bone Loss
por: Tawfeek, Hesham, et al.
Publicado: (2010)